LS CancerDiag Rebrands to Lynsight

Lynch Syndrome Research

Tumor-independent detection of inherited mismatch repair deficiency for the diagnosis of Lynch syndrome with high specificity and sensitivity

March 2023

Cancer Research Communications

Lynch Syndrome Genetics and Clinical Implications

January 2023

Cancer Research Communications

PMS2 expression decrease causes severe problems in mismatch repairĀ 

April 2019

Human Mutation

Predictive cancer diagnostics: LS CancerDiag Ltd has developed DiagMMR, an innovative method to detect cancer syndrome before cancers form.

August 2017

Pan European Networks

Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants

September 2016

Human Mutation

Assessing How Reduced Expression Levels of the Mismatch Repair Genes MLH1, MSH2, and MSH6 Affect Repair Efficiency

June 2014

Human Mutation

Application of a 5-Tiered Scheme for Standardized Classification of 2,360 Unique Mismatch Repair Gene Variants in the InSiGHT Locus-Specific Database

December 2013

Nature Genetic

Functional Analyses Help to Assess the Pathogenicity of MMR Gene Variants of Uncertain Significance

January 2013

DNA Alterations in Lynch Syndrome

Mismatch Repair Analysis of Inherited MSH2 and/or MSH6 Variation Pairs Found in Cancer Patients

May 2012

Human Mutation